of Public Health.

“This is an important finding because the Flint Men’s Health Study is one of a few studies conducted exclusively in a minority population that is known to be at high risk for developing prostate cancer,” Beebe-Dimmer says. Black men are 60 percent more likely to be diagnosed with prostate cancer, regardless of family history.

Older age and a family history of prostate cancer are the primary risk factors for the disease, in both blacks and whites. A first-degree relative with prostate cancer increases a man’s risk by two to four times, and the more relatives who are affected, the more the risk increases.

“Collecting a family history of prostate and breast cancer, especially among siblings, could be a key component of assessing prostate cancer risk among African-American men. A well-documented family history may signal a need for more intense prostate cancer screening,” says senior study author Kathleen Cooney, M.D., professor of internal medicine and urology at the U-M Medical School.

“In addition, these findings give potential to identifying new genes associated with prostate cancer or breast cancer,” adds Cooney, co-director of Urologic Oncology at the U-M Comprehensive Cancer Center.

Some 234,460 men will be diagnosed with prostate cancer this year, and 27,350 will die from the disease, according to the American Cancer Society.

Source-Newswse
SRM
'"/>




Page: 1 2
Related medicine news :

1. African-Americans Pose Less Questions To Treating Doctors
2. African-Americans Have A Reduced Response To Hepatitis C Treatment
3. Colorectal Cancer Survival Rates Poorer in African-Americans
4. Cancer Death Rates High in African-Americans
5. Cancer Doctors Okays Controversial Prostate Therapy
6. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
7. New Prostate Cancer Vaccine Shows Promise
8. Hormone Therapy applicable for Prostate Cancer
9. Prostate cancer and Vitamins
10. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
11. Early Detection Of Prostate Cancer